KEGG   PATHWAY: eju04936
Entry
eju04936                    Pathway                                
Name
Alcoholic liver disease - Eumetopias jubatus (Steller sea lion)
Description
Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
eju04936  Alcoholic liver disease
eju04936

Organism
Eumetopias jubatus (Steller sea lion) [GN:eju]
Gene
114199063  C1QC; complement C1q subcomponent subunit C [KO:K03988]
114222260  C2; complement C2 [KO:K01332] [EC:3.4.21.43]
114222096  complement C4-B-like [KO:K03989]
114226149  C3; complement C3 [KO:K03990]
114222571  C3AR1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
114212820  C5; complement C5 [KO:K03994]
114197037  C5AR1; C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
114203309  LOW QUALITY PROTEIN: lipopolysaccharide-binding protein-like [KO:K05399]
114203311  LOW QUALITY PROTEIN: lipopolysaccharide-binding protein-like [KO:K05399]
114220698  LBP; lipopolysaccharide-binding protein [KO:K05399]
114209490  CD14; LOW QUALITY PROTEIN: monocyte differentiation antigen CD14 [KO:K04391]
114214153  LY96; lymphocyte antigen 96 isoform X1 [KO:K05400]
114212737  TLR4; toll-like receptor 4 isoform X1 [KO:K10160]
114222344  TIRAP; toll/interleukin-1 receptor domain-containing adapter protein isoform X1 [KO:K05403]
114212285  MYD88; myeloid differentiation primary response protein MyD88 isoform X1 [KO:K04729]
114224086  IRAK4; interleukin-1 receptor-associated kinase 4 isoform X1 [KO:K04733] [EC:2.7.11.1]
114201598  IRAK1; interleukin-1 receptor-associated kinase 1 [KO:K04730] [EC:2.7.11.1]
114215395  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
114218356  TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform X1 [KO:K04403]
114209197  TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
114213021  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
114205217  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
114224851  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
114203804  IKBKG; NF-kappa-B essential modulator [KO:K07210]
114217931  NFKBIA; NF-kappa-B inhibitor alpha isoform X1 [KO:K04734]
114220346  RELA; transcription factor p65 [KO:K04735]
114199341  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
114222242  TNF; tumor necrosis factor [KO:K03156]
114223431  IL1B; interleukin-1 beta [KO:K04519]
114221211  IL6; interleukin-6 isoform X1 [KO:K05405]
114209150  IL12A; interleukin-12 subunit alpha [KO:K05406]
114211944  IL12B; interleukin-12 subunit beta [KO:K05425]
114206856  CXCL8; interleukin-8 [KO:K10030]
114226305  TICAM1; TIR domain-containing adapter molecule 1 [KO:K05842]
114206264  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
114221921  IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1 [KO:K07211] [EC:2.7.11.10]
114214962  TBK1; serine/threonine-protein kinase TBK1 isoform X1 [KO:K05410] [EC:2.7.11.10]
114199531  IRF3; interferon regulatory factor 3 isoform X1 [KO:K05411]
114203995  LOW QUALITY PROTEIN: interferon alpha-1/2-like [KO:K05414]
114212415  LOW QUALITY PROTEIN: interferon alpha-like [KO:K05414]
114212437  LOW QUALITY PROTEIN: interferon alpha-3-like [KO:K05414]
114212451  interferon alpha-14-like [KO:K05414]
114204306  LOW QUALITY PROTEIN: interferon alpha-1/2-like [KO:K05414]
114212404  IFNB1; interferon beta [KO:K05415]
114204366  IL17A; interleukin-17A isoform X1 [KO:K05489]
114222524  IL17RA; interleukin-17 receptor A isoform X1 [KO:K05164]
114207657  IL17RC; interleukin-17 receptor C isoform X1 [KO:K05166]
114203885  growth-regulated protein homolog beta-like [KO:K05505]
114206733  growth-regulated protein homolog gamma-like [KO:K05505]
114206753  growth-regulated protein homolog beta-like [KO:K05505]
114223997  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
114210338  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
114220353  FADD; FAS-associated death domain protein [KO:K02373]
114222480  TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
114202242  TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171]
114223527  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
114206181  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
114223902  RIPK1; receptor-interacting serine/threonine-protein kinase 1 isoform X1 [KO:K02861] [EC:2.7.11.1]
114202140  TAB3; TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 [KO:K12793]
114198206  SREBF1; sterol regulatory element-binding protein 1 isoform X1 [KO:K07197]
114216135  FASN; fatty acid synthase [KO:K00665] [EC:2.3.1.85]
114213809  ACACA; acetyl-CoA carboxylase 1 isoform X1 [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
114224904  SCD5; stearoyl-CoA desaturase 5 [KO:K00507] [EC:1.14.19.1]
114205242  SCD; acyl-CoA desaturase [KO:K00507] [EC:1.14.19.1]
114200309  LPIN2; phosphatidate phosphatase LPIN2 isoform X1 [KO:K15728] [EC:3.1.3.4]
114205859  LPIN1; phosphatidate phosphatase LPIN1 isoform X1 [KO:K15728] [EC:3.1.3.4]
114223188  LPIN3; phosphatidate phosphatase LPIN3 isoform X1 [KO:K15728] [EC:3.1.3.4]
114214155  SIRT1; NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
114221155  TRA2A; transformer-2 protein homolog alpha isoform X1 [KO:K12897]
114206988  TRA2B; transformer-2 protein homolog beta isoform X1 [KO:K12897]
114207063  ADIPOQ; adiponectin isoform X1 [KO:K07296]
114221913  ADIPOR1; adiponectin receptor protein 1 [KO:K07297]
114222553  ADIPOR2; adiponectin receptor protein 2 [KO:K07297]
114219018  CAMKK2; calcium/calmodulin-dependent protein kinase kinase 2 isoform X1 [KO:K07359] [EC:2.7.11.17]
114212116  PRKAA2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [KO:K07198] [EC:2.7.11.31]
114204800  PRKAA1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1 [KO:K07198] [EC:2.7.11.31]
114219011  PRKAB1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
114203347  5'-AMP-activated protein kinase subunit beta-2 [KO:K07199]
114203348  5'-AMP-activated protein kinase subunit beta-2 [KO:K07199]
114200181  PRKAG3; 5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200]
114225812  PRKAG1; 5'-AMP-activated protein kinase subunit gamma-1 isoform X1 [KO:K07200]
114197984  PRKAG2; 5'-AMP-activated protein kinase subunit gamma-2 isoform X1 [KO:K07200]
114210547  FOXO1; forkhead box protein O1 [KO:K07201]
114210013  FOXO3; forkhead box protein O3 [KO:K09408]
114197341  PPARGC1A; peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1 [KO:K07202]
114218347  PPARA; peroxisome proliferator-activated receptor alpha [KO:K07294]
114220165  CPT1A; carnitine O-palmitoyltransferase 1, liver isoform isoform X1 [KO:K08765] [EC:2.3.1.21]
114225362  ACADVL; very long-chain specific acyl-CoA dehydrogenase, mitochondrial isoform X1 [KO:K09479] [EC:1.3.8.9]
114208424  ACADM; medium-chain specific acyl-CoA dehydrogenase, mitochondrial [KO:K00249] [EC:1.3.8.7]
114216211  ACOX1; peroxisomal acyl-coenzyme A oxidase 1 isoform X1 [KO:K00232] [EC:1.3.3.6]
114197905  ACOX3; peroxisomal acyl-coenzyme A oxidase 3 isoform X1 [KO:K00232] [EC:1.3.3.6]
114223498  FABP1; fatty acid-binding protein, liver [KO:K08750]
114202984  alcohol dehydrogenase E chain [KO:K13951] [EC:1.1.1.1]
114202985  alcohol dehydrogenase E chain [KO:K13951] [EC:1.1.1.1]
114202910  alcohol dehydrogenase 4-like [KO:K13980] [EC:1.1.1.1]
114202913  alcohol dehydrogenase 4-like [KO:K13980] [EC:1.1.1.1]
114203126  alcohol dehydrogenase class-3 [KO:K00121] [EC:1.1.1.284 1.1.1.1]
114203129  alcohol dehydrogenase class-3 [KO:K00121] [EC:1.1.1.284 1.1.1.1]
114202912  alcohol dehydrogenase 6-like [KO:K13952] [EC:1.1.1.1]
114202915  alcohol dehydrogenase 6-like [KO:K13952] [EC:1.1.1.1]
114224513  aldehyde dehydrogenase, mitochondrial-like [KO:K00128] [EC:1.2.1.3]
114217289  aldehyde dehydrogenase, mitochondrial-like [KO:K00128] [EC:1.2.1.3]
114218492  aldehyde dehydrogenase, mitochondrial-like [KO:K00128] [EC:1.2.1.3]
114219023  aldehyde dehydrogenase, mitochondrial-like [KO:K00128] [EC:1.2.1.3]
114219083  ALDH2; aldehyde dehydrogenase, mitochondrial [KO:K00128] [EC:1.2.1.3]
114213574  ALDH1B1; aldehyde dehydrogenase X, mitochondrial [KO:K00128] [EC:1.2.1.3]
114198199  ALDH3A2; fatty aldehyde dehydrogenase isoform X1 [KO:K00128] [EC:1.2.1.3]
114199647  ALDH16A1; aldehyde dehydrogenase family 16 member A1 [KO:K00128] [EC:1.2.1.3]
114209580  ALDH7A1; alpha-aminoadipic semialdehyde dehydrogenase [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]
114210485  ALDH9A1; 4-trimethylaminobutyraldehyde dehydrogenase [KO:K00149] [EC:1.2.1.47 1.2.1.3]
114221828  cytochrome P450 2E1 [KO:K07415] [EC:1.14.14.-]
114219120  ACACB; acetyl-CoA carboxylase 2 isoform X1 [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
114202024  MLYCD; malonyl-CoA decarboxylase, mitochondrial [KO:K01578] [EC:4.1.1.9]
114218406  CPT1B; carnitine O-palmitoyltransferase 1, muscle isoform isoform X1 [KO:K19523] [EC:2.3.1.21]
114199644  CPT1C; carnitine O-palmitoyltransferase 1, brain isoform isoform X1 [KO:K19524] [EC:2.3.1.21]
114199716  NOX4; NADPH oxidase 4 isoform X1 [KO:K21423] [EC:1.6.3.-]
114203265  RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
114203268  RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
114206518  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
114215523  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
114214730  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
114212343  CTNNB1; catenin beta-1 [KO:K02105]
114209512  TCF7; transcription factor 7 isoform X1 [KO:K02620]
114223462  TCF7L1; transcription factor 7-like 1 [KO:K04490]
114202903  transcription factor 7-like 2 isoform X1 [KO:K04491]
114202904  transcription factor 7-like 2 isoform X1 [KO:K04491]
114222653  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
114220310  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
114222735  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
114197856  MAP2K4; dual specificity mitogen-activated protein kinase kinase 4 isoform X1 [KO:K04430] [EC:2.7.12.2]
114200845  MAP2K7; dual specificity mitogen-activated protein kinase kinase 7 isoform X1 [KO:K04431] [EC:2.7.12.2]
114224898  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
114201201  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
114205461  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
114198178  MAP2K3; dual specificity mitogen-activated protein kinase kinase 3 isoform X1 [KO:K04432] [EC:2.7.12.2]
114216197  MAP2K6; dual specificity mitogen-activated protein kinase kinase 6 isoform X1 [KO:K04433] [EC:2.7.12.2]
114218424  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
114218476  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
114222054  MAPK13; mitogen-activated protein kinase 13 isoform X1 [KO:K04441] [EC:2.7.11.24]
114222247  MAPK14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
114200618  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
Compound
C00003  NAD+
C00005  NADPH
C00006  NADP+
C00024  Acetyl-CoA
C00033  Acetate
C00040  Acyl-CoA
C00076  Calcium cation
C00083  Malonyl-CoA
C00084  Acetaldehyde
C00469  Ethanol
C22381  Reactive oxygen species
Reference
  Authors
Louvet A, Mathurin P
  Title
Alcoholic liver disease: mechanisms of injury and targeted treatment.
  Journal
Nat Rev Gastroenterol Hepatol 12:231-42 (2015)
DOI:10.1038/nrgastro.2015.35
Reference
  Authors
Gao B, Bataller R
  Title
Alcoholic liver disease: pathogenesis and new therapeutic targets.
  Journal
Gastroenterology 141:1572-85 (2011)
DOI:10.1053/j.gastro.2011.09.002
Reference
  Authors
Magdaleno F, Blajszczak CC, Nieto N
  Title
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
  Journal
Biomolecules 7:E9 (2017)
DOI:10.3390/biom7010009
Reference
  Authors
Lucey MR, Mathurin P, Morgan TR
  Title
Alcoholic hepatitis.
  Journal
N Engl J Med 360:2758-69 (2009)
DOI:10.1056/NEJMra0805786
Reference
  Authors
Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH
  Title
Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
  Journal
Gastroenterology 150:1756-68 (2016)
DOI:10.1053/j.gastro.2016.02.035
Reference
  Authors
Fujii H, Kawada N
  Title
Fibrogenesis in alcoholic liver disease.
  Journal
World J Gastroenterol 20:8048-54 (2014)
DOI:10.3748/wjg.v20.i25.8048
Reference
  Authors
Kim MS, Ong M, Qu X
  Title
Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
  Journal
World J Gastroenterol 22:8-23 (2016)
DOI:10.3748/wjg.v22.i1.8
Reference
  Authors
You M, Crabb DW
  Title
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
  Journal
Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)
DOI:10.1152/ajpgi.00056.2004
Reference
  Authors
Nagy LE
  Title
The Role of Innate Immunity in Alcoholic Liver Disease.
  Journal
Alcohol Res 37:237-50 (2015)
Reference
  Authors
Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S
  Title
Innate immunity in alcoholic liver disease.
  Journal
Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)
DOI:10.1152/ajpgi.00537.2010
Reference
  Authors
Wang HJ, Gao B, Zakhari S, Nagy LE
  Title
Inflammation in alcoholic liver disease.
  Journal
Annu Rev Nutr 32:343-68 (2012)
DOI:10.1146/annurev-nutr-072610-145138
Reference
  Authors
McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE
  Title
Complement Factor D protects mice from ethanol-induced inflammation and liver injury.
  Journal
Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)
DOI:10.1152/ajpgi.00334.2017
Reference
  Authors
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H
  Title
The effect of inflammatory cytokines in alcoholic liver disease.
  Journal
Mediators Inflamm 2013:495156 (2013)
DOI:10.1155/2013/495156
Reference
  Authors
Szabo G, Bala S
  Title
Alcoholic liver disease and the gut-liver axis.
  Journal
World J Gastroenterol 16:1321-9 (2010)
DOI:10.3748/wjg.v16.i11.1321
Reference
  Authors
Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H
  Title
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
  Journal
Int J Mol Med 40:263-270 (2017)
DOI:10.3892/ijmm.2017.3015
Reference
  Authors
Roh YS, Seki E
  Title
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
  Journal
J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)
DOI:10.1111/jgh.12019
Reference
  Authors
Rogers CQ, Ajmo JM, You M
  Title
Adiponectin and alcoholic fatty liver disease.
  Journal
IUBMB Life 60:790-7 (2008)
DOI:10.1002/iub.124
Reference
  Authors
You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P
  Title
Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
  Journal
Curr Mol Pharmacol 10:226-236 (2017)
DOI:10.2174/1874467208666150817112109
Reference
  Authors
You M, Jogasuria A, Taylor C, Wu J
  Title
Sirtuin 1 signaling and alcoholic fatty liver disease.
  Journal
Hepatobiliary Surg Nutr 4:88-100 (2015)
DOI:10.3978/j.issn.2304-3881.2014.12.06
Reference
  Authors
Ren R, Wang Z, Wu M, Wang H
  Title
Emerging Roles of SIRT1 in Alcoholic Liver Disease.
  Journal
Int J Biol Sci 16:3174-3183 (2020)
DOI:10.7150/ijbs.49535
Reference
  Authors
Purohit V, Gao B, Song BJ
  Title
Molecular mechanisms of alcoholic fatty liver.
  Journal
Alcohol Clin Exp Res 33:191-205 (2009)
DOI:10.1111/j.1530-0277.2008.00827.x
Reference
  Authors
Hyun J, Han J, Lee C, Yoon M, Jung Y
  Title
Pathophysiological Aspects of Alcohol Metabolism in the Liver.
  Journal
Int J Mol Sci 22:5717 (2021)
DOI:10.3390/ijms22115717
Reference
  Authors
Combs TP, Marliss EB
  Title
Adiponectin signaling in the liver.
  Journal
Rev Endocr Metab Disord 15:137-47 (2014)
DOI:10.1007/s11154-013-9280-6
Reference
  Authors
Ceni E, Mello T, Galli A
  Title
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
  Journal
World J Gastroenterol 20:17756-72 (2014)
DOI:10.3748/wjg.v20.i47.17756
Reference
  Authors
Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T
  Title
Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
  Journal
Int J Mol Sci 20:E2712 (2019)
DOI:10.3390/ijms20112712
Reference
  Authors
Ohashi K, Pimienta M, Seki E
  Title
Alcoholic liver disease: A current molecular and clinical perspective.
  Journal
Liver Res 2:161-172 (2018)
DOI:10.1016/j.livres.2018.11.002
Reference
  Authors
You M, Arteel GE
  Title
Effect of ethanol on lipid metabolism.
  Journal
J Hepatol 70:237-248 (2019)
DOI:10.1016/j.jhep.2018.10.037
Reference
  Authors
Bi L, Jiang Z, Zhou J
  Title
The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
  Journal
Alcohol Alcohol 50:146-51 (2015)
DOI:10.1093/alcalc/agu102
Reference
  Authors
Ali H, Assiri MA, Shearn CT, Fritz KS
  Title
Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.
  Journal
Curr Opin Toxicol 13:110-117 (2019)
DOI:10.1016/j.cotox.2018.10.003
Reference
  Authors
Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M
  Title
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
  Journal
Gastroenterology 146:801-11 (2014)
DOI:10.1053/j.gastro.2013.11.008
Reference
  Authors
Stickel F, Hampe J
  Title
Genetic determinants of alcoholic liver disease.
  Journal
Gut 61:150-9 (2012)
DOI:10.1136/gutjnl-2011-301239
Reference
  Authors
Yang CF, Zhong YJ, Ma Z, Li L, Shi L, Chen L, Li C, Wu D, Chen Q, Li YW
  Title
NOX4/ROS mediate ethanolinduced apoptosis via MAPK signal pathway in L02 cells.
  Journal
Int J Mol Med 41:2306-2316 (2018)
DOI:10.3892/ijmm.2018.3390
Related
pathway
eju00061  Fatty acid biosynthesis
eju00071  Fatty acid degradation
eju01040  Biosynthesis of unsaturated fatty acids
eju03040  Spliceosome
eju04010  MAPK signaling pathway
eju04064  NF-kappa B signaling pathway
eju04152  AMPK signaling pathway
eju04210  Apoptosis
eju04310  Wnt signaling pathway
eju04610  Complement and coagulation cascades
eju04620  Toll-like receptor signaling pathway
eju04657  IL-17 signaling pathway
eju04668  TNF signaling pathway
eju04920  Adipocytokine signaling pathway
eju05034  Alcoholism
eju05225  Hepatocellular carcinoma
KO pathway
ko04936   
LinkDB

DBGET integrated database retrieval system